GEODE CAPITAL MANAGEMENT, LLC
Position in TNXP — Tonix Pharmaceuticals Holding Corp.
CIK 1214717
BOSTON, MA
Position in TNXP
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,043,517
+$735,767 QoQ
Shares Held
395,260
+26.2% QoQ
Ownership
2.30%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 103 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNXP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. TNXP ranks #242 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in TNXP
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,043,517 | 395,260 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,307,750 | 313,291 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,247,139 | 271,904 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,854,564 | 200,934 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $6,304,127 | 175,212 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,109,221 | 62,037 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $650,724 | 1,971,894 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $17,398 | 115,987 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $11,581 | 16,546 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $75,754 | 398,706 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $42,644 | 106,611 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $69,463 | 126,297 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $134,876 | 85,365 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $314,771 | 533,511 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $145,022 | 371,852 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $182,298 | 343,960 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $209,903 | 132,850 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,751,509 | 7,615,258 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,592,219 | 7,200,611 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,453,995 | 7,423,326 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,129,124 | 5,521,734 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,707,797 | 2,896,717 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $628,884 | 924,830 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $602,876 | 717,710 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $65,037 | 106,619 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $59,975 | 84,472 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||